MICROBIAL PATHOGENS CAUSING COMMUNITY-ACQUIRED PNEUMONIA IN HOSPITALIZED ADULT PATIENTS WITH DIABETES AND NONDIABETES
Main Article Content
Abstract
Background: Community-acquired pneumonia in diabetic patients often progresses seriously and has a high mortality rate. Therefore, accurately identifying the microbiological agents causing community-acquired pneumonia in diabetic patients contributes to improving treatment effectiveness, minimizing complications and effective prevention. Aims: Determine the rate of microbiological agents causing community-acquired pneumonia in hospitalized adults with and without diabetes mellitus and its relationship. Methods: This study was a cross-sectional descriptive design in prospect conducted on sputum of hospitalized community-acquired pneumonia patients with and without diabetes mellitus. The research method used multiplex real-time PCR technique to identify pathogens and chi-square test to determine the relationship. Results: The highest proportion of bacteria causing community-acquired pneumonia in patients with and without diabetes included K. pneumoniae, A. baumannii, H. influenzae, E. coli, and S. pneumoniae. Influenza virus and Candida accounted for the majority in both groups of patients, but Influenza virus type B and Candida albicans as well as Candida tropicalis were detected at a higher rate in diabetic patients than in patients without diabetes with p < 0.05. Conclusions: Gram-negative bacteria, Influenza virus, and Candida fungi accounted for the majority in the two groups of patients, but Influenza virus type B, Candida albicans, and Candida tropicalis are detected in patients with diabetic mellitus at a higher rate than in patients without diabetes mellitus and the difference is statistically significant (p < 0.05).
Article Details
Keywords
microbial agent, community-acquired pneumonia, diabetes mellitus.
References
2. Liu X, Zhao Q, He X, Min J, RSY, Chen Z, Ma J, Hu W, Huang J, Wan H, et al. Clinical characteristics and microbial signatures in the lower airways of diabetic and nondiabetic patients with pneumonia. J Thorac Dis. 2024;16(8):5262-5273. https://doi.org/10.21037/jtd-24-490.
3. Klekota RB, Mizgala E, Ksól W. The etiology of lower respiratory tract infection in people with diabetes. Pneumonol Alergol Pol.2015;83:401-408. https://doi.org/10.5603/piap.2015.0065 .
4. Phạm Hùng Vân, Nguyễn Văn Thành, Trần Văn Ngọc và cộng sự. Tác nhân vi sinh gây viêm phổi cộng đồng phải nhập viện – Kết quả nghiên cứu REAL 2016-2017. Thời sự Y học. 2018 (3.2018):51-63.
5. Ahmed MS, Reid E. Respiratory infections in diabetes: Reviewing the risk and challenges. J Respir Dis.2008:29(7):285-293.
6. Ahmed JU, Hossain MD, Rahim MA, Afroz F, Musa AKM. Bacterial etiology and antibiotic sensitivity pattern of community-acquired pneumonia in diabetic patients: Experience in a tertiary care hospital in Bangladesh. Birdem Med J.2017;7(2): 101-105. https://doi.org/10.3329/ birdem.v7i2.32445.
7. Yacovo SD, Garcia-Vidal C, Viasus D, Adamuz J, Oriol I, Gili F, Vilarrasa N, García-Somoza MD, Dorca J, Carratalà J. Clinical features, etiology and outcomes of community-acquired pneumonia in patients with diabetes mellitus. Medicine (Baltimore).2023;92:42-50. https://doi.org/10.1097/md.0b013e31827f602a.
8. López-de-Andrés A, de Miguel-Diéz J, Jiménez-Trujillo I, Hernández-Barrera V, de Miguel-Yanet JM, Méndez-Bailón M, Pérez-Farinós N, Salinero-Fort MAN, Jiménez-García R. Hospitalization with community-acquired pneumonia among patients with type diabetes: an observation-population-based study in Spain from 2004 to 2013.BMJ Open.2017;7: e013097. https://doi.org/10.1136/bmjopen-2016-013097.